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ABSTRACT: The Bentall procedure introduced in 1968 represents an undisputed cure to treat multiple pathologies 
involving the aortic valve and the ascending thoracic aorta. Over the years, multiple modifications have been intro-
duced as well as a standardized approach to the operation with the goal to prevent long-term adverse events. The 
BioValsalva prosthesis provides a novel manner to more efficiently reconstruct the aortic valve together with the 
anatomy of the aortic root with the implantation of a valved conduit. This prosthesis comprises three sections: the 
collar supporting the valve; the skirt mimicking the Valsalva, which is suitable for the anastomoses with the coronary 
arteries; and the main body of the graft, which is designed to replace the ascending aorta. The BioValsalva prosthesis 
allows the Bentall operation to be used in patients whose aortic valve cannot be spared.
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I. INTRODUCTION 
The Bentall procedure is a cardiac surgery involving 
the aortic valve (either repair or replacement), the 
aortic root, and the ascending aorta, with reimplan-
tation of the coronary arteries. This procedure was 
first described by Bentall and De Bono in 1968 and 
is now commonly used to cure a wide spectrum of 
pathologic conditions involving both the aortic valve 
and the ascending aorta.1 This procedure is gener-
ally necessary in cases of tissue lost, aneurysmal 
degeneration, acute dissection, aortic stenosis with 
small root, and porcelain aorta.2 Over the years, sur-
geons have proposed multiple modifications to the 
original technique in response to adverse events.3–5 
The valve-sparing procedure proposed by David be-
came widely accepted because the reimplantation 
technique allowed preservation of the aortic valve.6,7 
In 1980, Kouchoukos et al. recommended the open-
button technique to prevent the formation of pseu-
do-aneurysms at the site of coronary anastomosis.8 
This technique was further modified by Michialon 
et al. in 2001 to prevent the valve graft from tearing 
and to reduce coronary button anastomosis tension.9 
In 2007, Albertini et al. recommended the double 
sewing-ring technique to simplify reoperation due 
to valve degeneration.10 The benefits of selecting ho-
mografts were seriously hampered by the difficul-
ties of procurement.11–13 Other devices manufactured 
with chemically treated biological tissues showed 
interesting possibilities but remained marginal.14–17 
Adverse events were frequently related to the stress 
at the anastomoses with the coronary arteries.18–22 
These multiple innovations were designed with the 
intent to minimize recognized complications but did 
not result in a real consensus.23–26 The Bentall op-
eration, with the implantation of a prosthetic valve 
(bioprosthesis or mechanical valve), became the 
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most accepted procedure;27 however, many ques-
tions emerged.28,29 Based on sound clinical experi-
ence, De Paulis developed a prosthesis to make this 
surgical technique more accessible and to maximize 
the durability of the procedure.30–32 The BioValsalva 
consists of tubular fabrics valves with bioprostheses 
fitted in a Triplex conduit.33–35 We hereby report our 
analyses of the Triplex BioValsalva valve prostheses 
to reconstruct the aortic valve and the aortic root.
II. MATERIALS AND METHODS 
A. Devices
Two Triplex BioValsalva prostheses—one stented, 
one non-stented—were investigated. These devices 
were manufactured by Vascutek, a Terumo Com-
pany (Inchinnan, Scotland, UK), based on research 
conducted by De Paulis et al. to more consistently 
repair and replace the aortic valve together with 
the pathological ascending thoracic aorta (e.g., an-
eurysm, dissection, or coarctation).21 The Triplex 
BioValsalva device consisted of three sections: a 
collar, a skirt, and a body. The collar of the first de-
vice supported a stented porcine valve, whereas the 
collar of the second supported a non-stented valve. 
In both devices, the fabric was a self-sealing graft 
material called Triplex that consists of three layers: 
inner woven polyester, central SEPS (styrene ethyl-
ene propylene styrene block copolymer, a thermo-
plastic elastomer), and an outer PTFE coating.35,36 
This fabric conduit is similar to the Valsalva that 
has been investigated previously.37 However, in this 
device, zero water permeability was achieved with 
a degradable gelatin coating.38 The selected por-
cine bioprostheses were the Elan Vascutek-Terumo, 
stented and nonstented, whose respective perfor-
mances have been reported previously.39,40
B. Testing
1. Non-?estructive ?esting
Gross observations were performed on the devices 
as received from the manufacturer. To identify any 
flaws, photographs were taken using a digital cam-
era (Song DSC F707, 5 megapixels). The images 
were processed with Adobe Photoshop CS4. A poly-
ester, 4-mm-diameter graft was anastomosed to the 
Valsalva of the unstented BioValsalva device in our 
laboratory after a 4-mm-diameter hole was cut in the 
wall using a surgical blade. The skirt was punctured 
using a trocar to mimic the air purge before restoring 
the blood flow.
For micro-computed tomography (Micro-CT) 
investigations, the devices were placed on the ex-
amination bed (width, 75 mm) of the eXplore Locus 
Micro-CT Scanner ( GE Healthcare, London, On-
tario, Canada) and set on the rotating stage. X-ray 
settings of 80 kV and 450 μA were applied to the 
devices over 360° rotation, with an exposure time 
of 100 ms per frame. The effective pixel size was 92 
μm. The scanner produced a 2D projection image in 
0.9° angular increments around the device, resulting 
in 400 views with 10 min scanning time. The 2D 
projections were reconstructed at a 3D volume using 
a modified Feldkamp cone-beam algorithm to allow 
voxel-driven convolution and back projection. The 
400 views were reconstructed and analyzed using 
Reconstruction Utility software and eXplore Mi-
croView v. 2.0 (GE Healthcare, Madison, WI).
2. Destructive ?esting: ?istology of the 
?ioprostheses
Tissue samples (3 to 5 mm wide, 1 cm long) were 
dissected from each leaflet of each prosthesis and 
processed for scanning electron microscopy, light 
microscopy, and transmission electron microscopy.
Scanning electron microscopy studies were 
conducted as follows: After post-fixation in a 1% 
osmium tetroxide, the specimens were rinsed in 
distilled water, dried in ethanol solutions of graded 
concentrations until the use of absolute ethanol 
and transferred in absolute acetone. Final drying 
was achieved in hemaxamethyldisilazane. After 
gold-palladium coating, (Sputter Coater Nanotech 
Semprep2 Nano-Tech Burton on Trent, UK), the 
specimens were observed by scanning electron mi-
croscopy (Jeol, JSM-6360LV, Jeol, Tokyo, Japan) at 
accelerating voltages ranging from 15 kV to 25kV.
For light microscopy, the specimens were em-
bedded in paraffin, cut in 5-µm-thick slides using a 
microtome. Sections were stained with hematoxy-
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lin and eosin (HE) for general observation using a 
polarized microscope; with Masson’s trichrome for 
the visualization of collagen; with Weighert and 
Verhoeff for visualization of elastic fibers; and with 
red picrosirius for examining the waviness of the 
collagen bundles. The slides were observed in Axio 
Imager M2 (Zeiss, Jena, Germany), and the photos 
were processed with the Axio Vision Release 4.2.2 
progiciel. 
Transmission electron microscopy was con-
ducted as follows: After post-fixation in 1% osmium 
tetroxide solution followed by uranylacetate stain-
ing, specimens were embedded in Epon and cut in 
thin sections using an ultramicrotome. Following 
additional lead citrate and uranylacetate staining, 
the samples were observed by transmission electron 
microscopy at a voltage of 80 kV in a Jeol JEM 
1230. 
3. Destructive ?esting: ?abric
The fabric analysis was based on the recommen-
dations of the ISO 7198-1998 for tubular vascular 
prosthesis41 and was adapted from the protocols that 
we previously used for testing fabric conduits.42–44
For dissection of the device and related obser-
vations, each device was opened longitudinally and 
divided into two identical halves to be photographed 
with a digital camera. Each specimen was observed 
using light microscopy under a 10× magnification 
before and after elimination of the outer elastomer 
layer. The fabric and its coating were boiled for 
10 minutes in a 99.5% solution of cyclohexanone 
(C6H10O). After cooling overnight at room tempera-
ture, the specimens were rinsed twice in distilled 
water and air dried. Each specimen was observed 
under 10× magnification to confirm the complete 
removal of the coating. If any trace was found, the 
procedure was repeated. 
Morphology of the walls of the different sec-
tions of Valsalva graft, before and after removing 
the coating, were determined as follows: Using light 
microscopy, the specimens were observed with a 
PXS8-T optical compound microscope (Shanghai 
Cewei Photoelectric Technology, Shanghai, China) 
with CCD of Nikon Digital Sight DS.Fil (Nikon 
Imaging, Shanghai, China) fitted with an eyepiece 
scale at a ×10 magnification. For scanning electron 
microscopy, the fabric specimens (0.5×0.5 cm2) were 
made conductive by sputter coating with platinum 
and examined in a Jeol JSM-5600LV environmen-
tal scanning electron microscope at an accelerating 
voltage of 15 kV. 
Structures of the woven fabrics were observed 
with a light microscope. The pattern of the fabrics 
was drawn according to the observations using the 
following measurements. For the fabric count, the 
number of ends and picks per unit in the woven 
fabric were measured at 40× magnification. The 
number of ends and picks within 1 mm was counted 
using MB-Ruler software. Twenty locations were 
randomly selected on each fabric specimen to obtain 
the mean value and standard deviation.
To determine thickness, a thickness gauge mod-
el CH-12.7-BTSX (Shanghai Liuling Instrument, 
Shanghai, China) with a minimum division of 0.001 
mm was employed to measure the fabric thickness 
after cleaning. The diameter of the columniform 
gauge head is 5 mm; the area of the presser foot is 
19.63 mm2; and the testing pressure is 22±5 KPa 
(44±10 g). Ten different locations were randomly 
selected for each specimen.
The mass of the fabric specimens was measured 
with an electronic analytical balance model FA2004 
(Shanghai Liangping Instrument, Shanghai, China) 
with 0.1-mg resolution. Specimens of 1×1 cm2 in 
size were selected at three locations on both cleaned 
fabrics. Each specimen was measured five times to 
calculate the mean and standard deviation. The mass 
per unit area (g/cm2) of the fabric specimens was 
then determined.
The porosity (P) of the fabric, i.e., the volume of 
the void space as a proportion of the total volume of 
the fabric, was calculated as follows:
P = 100 X (1 X M____tr 
where M is the mass per unit area (g/cm2), t is the 
thickness in centimeters, and ρ is the density (1.38 
g/cm3) of the polyester fibers.
To determine the number of filaments in each 
yarn, the three types of yarns in each fabric (i.e., up-
per warp yarns, inner warp yarns, and weft yarns) 
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were separated from ten different locations with 
tweezers under a magnifier. The number of the fila-
ments in each yarn was counted three times to guar-
antee the accuracy of the count. Special attention 
was aimed toward avoiding yarn breakage and fiber 
entanglement during the procedure. 
To determine the filament diameters, individual 
filaments were removed, and their diameters were 
determined using a light microscope model CH-2 
(Nikon Imaging) at a magnification of 400×. MB-
Ruler software was employed to precisely measure 
the diameter of the filaments. Each filament was 
gauged 50 times to determine the mean and standard 
deviation.
Linear density of yarns and filaments, i.e., mass 
per unit length of fibers or yarns, was determined in 
decitex (dtex), i.e., the mass in decigrams per kilo-
meter of yarn or fiber. The nominal linear density 
was calculated using the following equation: 
d(dtex) =   n __100 × 
πD2__ 4     ρ
where ρ is the density (1.38g/cm3) of polyester fi-
bers, D is the average filament diameter in microm-
eters, and is n the number of filaments in each yarn.
To assess the mechanical performances of the 
filaments, 20 individual filaments were pulled from 
both warp and weft yarns selected from ten different 
locations of the fabric specimens. Special attention 
was aimed toward preventing any accidental tension 
imposed on the fiber likely to make the measure-
ments inaccurate. A fiber tensile tester model XQ-2 
(Shanghai Lipu Applied Science and Technology 
Research Institute, Shanghai, China) was used to 
test the tensile performances of the filaments at a 
stretching speed of 10 mm/min with a pre-tension of 
0.75cN/dtex and a clamping distance of 10 mm. For 
each type of filament, the test was repeated 20 times 
to calculate the average and standard deviation.
The surface chemistry was first examined in an 
X-ray photoelectron spectroscope (XPS). The sur-
vey analysis of the surface elemental composition 
was performed on the different sections of the blood 
conduits, i.e., the skirt and the body. The coupons 
were selected in the devices as received and after 
cleaning i.e., digestion of the external layer (SEPS 
with the outer PTFE layer). The analyses were con-
ducted using a Thermo VG 200iXL (VG Sientia, 
Newburg Port, MA, USA) with a non-monochro-
matized AlKα source without charge compensation.
The surface chemistry of the BioValsalva fabric 
was also examined using a Fourier transform infra-
red imaging microscope (FTIR-IM) model Nicolet 
IN 10MX (Thermo Fisher Scientific, Waltham, 
MA, USA) and was compared to the surface of the 
polyester fabric after digestion of the self-sealing 
polymer. The specimens were flattened and pressed 
against the crystal prism of the attenuated total 
internal reflectance (ATR) system to observe the 
absorption bands. The spectra were analyzed using 
proprietary software Omnic V 6.0.
Using differential scanning calorimetry (DSC), 
the thermal properties of the blood conduit from 
the explant and the control were measured (Model 
204F1, Netzsh Scientific Instruments, Shanghai, 
China). Specimens of approximatively 3–4 mg each 
were cut and loaded into aluminum pans and sealed. 
The pans were heated from 50°C to 300°C at the 
same heating rate. The data were collected and ana-
lyzed with the Proteus thermal analysis software to 
calculate the onset and peak temperatures, heat of 
fusion, crystallinity, and glass transition temperature 
(Tg) of all endotherms and exotherms.
III. RESULTS
A. Gross Observations
The BioValsalva prostheses possessed the elements 
necessary to perform the Bentall operation with a 
valved conduit: the three sections of the devices 
were well differentiated (Figures 1 and 2). The por-
cine bioprostheses, either unstented or stented, were 
fixed at the collar. The second section, by the name 
of the skirt, was belly shaped to permit the anas-
tomosis of the coronary arteries without tension. It 
mimicked the Valsalva and thus could reduce the 
risk of false aneurysms at the suture lines of the 
coronary conduits. The third section was defined as 
the body to serve as the outflow of the device. The 
crimps were perpendicular to the blood flow. This 
section could be trimmed by the surgeon to fit in 
the site of implantation. The anastomoses between 
the different sections were regular without any 
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FIG. 1: Gross observation of the BioValsalva prostheses. Each device (A1, B1) holds three sections, the collar support-
ing the valve, the Valsalva and the skirt. The Valsalva is belly shaped to anastomose the coronary conduit with reduced 
tension whereas the skirt is crimped perpendicularly to the blood flow. The valves are bioprostheses made of porcine 
aortic valve. In the unstented device, the porcine valve is scalloped and immobilized with sutures attached to the Val-
salva (A2) in addition to the fixation to the collar. In the stented device the valve is only attached at the collar (B2).
FIG. 2: Gross observation of the porcine valve in the unstented BioValsalva device. The bioprosthesis that is scalloped 
in the aorta is anastomosed to the collar and sutured to the Valsalva (A). The leaflets show a good cooptation (B) and 
the semilunar leaflets or cusps are attached to the aorta and are flawless. They can be identified as left coronary (L1), 
non-coronary (L2) and right coronary (L3).
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fraying of the woven fabric. When observed with 
the naked eye, all the sections of the prostheses ap-
peared flawless.
The suture of a coronary polyester conduit 
was easily performed by means of a monofilament 
polypropylene suture and the anastomosis did not 
show any fraying of the structure. The perforation 
of the body by means of a trocar to mimic the de-
gasing showed some mild fraying but the hole did 
not stretch. Such a hole can be repaired by a single 
suture stitch (Figures 3-5). The valves were flawless 
as it was confirmed in Micro CT Scan observation 
(Figure 6). A good placement of the commissures of 
the leaflets was observed with a complete juxtapo-
sition along their entire length. These commissures 
were soft. No hematoma within the leaflets or the 
septal shelf was evidenced.
B. Destructive Analyses: Histology of the 
Valves
1. Scanning ??ectron ?icroscopy
The leaflets of the unstented BioValsalva showed a 
smooth surface on the inflow side (ventricular). The 
subendothelial layer was devoid of any endothelial 
cells because they were eliminated during the pro-
cessing. At higher magnification, the flow surface 
was corrugated according to the morphology of the 
underneath layers of elastin fibers and waved col-
FIG. 3: Suturing a coronary conduit to the Valsalva to mimic the anastomosis of a coronary graft. A 4-mm spirally 
supported polyester graft is anastomosed with a 6.0 monofilament polypropylene suture after opening a 4-mm-diame-
ter orifice in the Valsalva (A). The anastomosis can be completed (B), without any adverse effect on the leaflet coopta-
tion. In addition (C) no fraying of the fabric can be seen.
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FIG. 4: Insertion of trocar through the wall of the skirt of the stented device to permit complete degassing of the ex-
tracorporeal circuit before restoring the blood flow (A, B). The mild trauma caused by this procedure can be revised 
by means of a simple suturing after the trocar is pulled out (C, D).
FIG. 5: Anastomosis of a coronary conduit to the stented BioValsalva. The inflow shows a perfect cooptation of the 
three leaflets (A). The outflows together with the ostia of the coronary conduit are observed within the Valsalva (B). 
The valve can open as observed on the outflow side without fraying of the fabric at the ostia with the coronary conduit 
(C). A more detailed observation confirms the feasibility of the procedure (D). 
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lagen bundles. The outflow (fibrosa) was frequent-
ly somewhat crimped or corrugated. This crimped 
configuration corresponded to the fixation during 
the systole as the result of the contraction of the un-
derneath structure of the collagen wavy crimps. The 
few shallow fractures on the surface were probably 
an artifact caused by the flattening of the sample of 
the specimen on the stub. The marks of the surgi-
cal tools used to suture the valve to the skirt were 
evidenced. This trauma was only a surface phenom-
enon (Figures 7–9).
The flawed surface of the leaflets of the stented 
BioValsalva showed a similar morphology, but there 
was no mark of the surgical tweezers on their sur-
faces (Figures 10–12).
FIG. 6: Micro CT scan observation of the stented device 
after suturing a coronary graft (left) and the unstented de-
vice (right). The coronary branch is anastomosed to the 
Valsalva of the first one (A1), whereas the scalloped aor-
tic valve is sutured to the Valsalva (B1). The co-optations 
at the inflow of the leaflets of both valves are adequate in 
both devices (A2, B2). The observations of the outflow 
are similar (A3, B3).
FIG. 7: Leaflet 1 in the unstented BioValsalva device. 
The inflow is smooth with a corrugated smooth surface 
with minor irregularities (A1). The subendothelial layer 
is continuous and devoid of endothelial cells previously 
eliminated during the processing. The shallow undula-
tions follows the underneath structures of the waviness 
of the collagen and elastic fibers (A2,A3). The outflow 
shows an irregularity undulated surface with prints result-
ing from the handling of the valve during suturing (B1). 
The surface is mildly damaged with undulations follow-
ing the structures of the underlying collagen bundles in 
addition to the corrugations at the systole (B2). At higher 
magnification, the subendothelial layer is shown continu-
ous and regular (B3).
2. Light ?icroscopy
The section through the leaflets showed three lay-
ers: the lamina ventricularis at the inflow and the 
lamina fibrosa at the outflow with the lamina fibrosa 
BioValsalva Prostheses 57
JLT Volume 26, Issue 1, 2016
FIG. 8: Non-coronary leaflet in the unstented BioVal-
salva. The inflow side does not show the same smooth-
ness (A1), but the subendothelium is well preserved and 
continuous (A2); some ghost cells are suspected (A3). 
The outflow shows many prints of surgical tools that ap-
plied pressure on the mildly corrugated valve (B1). The 
fractures in the subendothelial were aggravated by the 
immobilization of the tissues on the stub for observation 
in SEM (B2). The underneath bundles of collagen show 
waviness. The fibers are well differentiated (B3).
in between. These layers had a complex architecture 
designed to accommodate the repetitive changes 
during opening (systole) and closing (diastole). In 
the ventricularis, elastin and collagen showed vari-
ous levels of stretching and waviness because they 
extended during the systole. The fibrosa frequently 
showed a corrugated structure because of the un-
derneath bundles of collagen that stretches during 
the diastole to maintain coaptation and prevent any 
FIG. 9: Right coronary leaflet in the unstented BioVal-
salva. The inflow side is smooth but not flat and holds 
local belly configurations (A1). The subendothelial layer 
is continuous without any fracture (A2, A3). The out-
flow side shows a corrugated structure with longitudinal 
disruptions in the direction of the corrugations and the 
marks of surgical tools (B1, B2). The collagen bundles 
are visible underneath the disruption in the subendothe-
lium (B3).
aortic leak are retracted during the systole. The 
spongiosa, frequently the thickest layer composed 
of loosely arranged collagen and abundant glyco-
soaminoglycans (GACs). All three layers incorpo-
rated large amounts of interstitial cells. The fibrosa 
involved the formation of an important member of 
protuberances. Both ventricular and fibrosa in their 
non-appositional areas and the free margins together 
with the spongiosa were accompanied by a signifi-
cant presence of intersticial cells. The observations 
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FIG. 10: Leaflet 1 in the stented BioValsalva device. The 
inflow is smooth with smooth, low-profile belly undula-
tion (A1). The subendothelial layer is well preserved and 
follows the morphology of the underneath waviness of 
the collagen bundles (A2). The outflow is waved with 
disruptions parallel to the folds (B1). The fissures are ag-
gravated by the immobilization of the sample on the stub 
after drying (B2). The subendothelial layer splits permit 
to locally identify the underlying fibers. It holds ghost en-
dothelial cells (B3).
in the unstented prosthesis were similar to those in 
the stented prosthesis (Figures 13–18).
3. Transmission ?lectron ?icroscopy
In both, unstented and stented BioValsalva devices, 
the leaflets showed a great variability in the con-
tent in collagen bundles. There were empty spaces 
between the cells and the collagen. The collagen 
bundles showed waviness whatever the quantity of 
collagen fibers in each bundle. These fibers were 
never agglutinated; they were totally individualized. 
In addition, the characteristic banding of collagen 
FIG. 11: Non coronary leaflet in the stented BioValsalva 
device. The inflow shows a smooth and continuous sub-
endothelial surface with some moderately low-profile 
swollen areas (A1). There is no disruption in this sub-
endothelial layer (A2) whose microstructure follows the 
underneath structure of the collagen bundles (A3). The 
outflow holds a major corrugation with longitudinal 
splits in the subendothelial layer parallel to this corruga-
tion (B1). These fissures permit to visualize the underly-
ing bundles of collagen (B2). The ghosts of endothelial 
cells from the endothelium are visible (B3).
filaments was always visible and clearly identified 
on every single collagen fibril (Figures 19–24).
C. Destructive Analyses: Textile 
Investigations
The scanning electron microscopy photos of the 
blood conduits taken before eliminating the Triplex 
coating confirmed the complete imperviousness of 
the prosthetic walls in the different sections (Figure 
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FIG. 12: Right coronary leaflet in the stented BioValsalva 
device. The smoothness of the outflow shows a low-profile 
belly structure in the vicinity of the undulations of the sur-
face (A1). The flow surface shows some desquamation of 
the ghost cells of the endothelium (A2, A3). The outflow of 
the leaflet was locally corrugated and mostly flat (B1). The 
fractures in the subendothelial layer make the underlying 
structures of collagen bundles visible (B2). Otherwise, the 
surface is smooth with ghost of endothelial cells (B3).
25). The warp and weft yarns interlaced with each 
other to form the final structure of the fabric. The 
different sections were securely anastomosed with 
braided polyester. The anastomosis stitches were 
regular, and the woven structure of the fabric did not 
show any fraying in the unstented device or in the 
stented device.
1. Fabric ?tructure and ?abric ?ount
The fabric structure of the skirt and the body sec-
tions was a backed weave consisting of two systems 
of warp threads (face warp and back warp) and one 
FIG. 13: Light microscopy photomicrographs of the 
left coronary leaflet of the unstented BioValsalva de-
vice. They are shown from the inflow to the outflow: the 
ventricularis, the spongiosa and the fibrosa. Its thickness 
is variable i.e., between 200 μm and 700 μm. The ven-
tricularis, i.e., the inflow, shows bundles of collagen and 
elastin not organized in a specific direction. The fibrosa 
is the outflow, whose thickness ranges between 150 μm 
and 250 μm, holds large bundles of collagen that are ori-
ented predominantly in the circumferential direction of 
the leaflet. It explains the frequent presence of corruga-
tions observed in scanning electron microscopy. The fi-
brosa is shown as a buffer between the ventricularis and 
the fibrosa. It holds loosely arranged collagen and elas-
tin fibers within the glycoaminoglycans. The endothelial 
cells were destroyed during the processing and thus only 
ghosts of endothelial cells can be observed. The subendo-
thelium is intact without any rupture, nor fragmentation. 
An abundant cellularity is visible in the ventricularis and 
the fibrosa.
system of weft. The back warps interweave with the 
wefts to form the back weave, which was 1-warp/1-
weft, namely plain weave, while the face warps were 
over the plain weave every other two warps to form 
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cleaning (Table 1). Therefore, no coating remained 
on the surface of the fabric. The fabric structure of 
the two sections in both devices was a warp-backed 
weave with a thickness of 0.271 mm and a mass of 
0.0124 g/cm2. The porosity calculated according to 
the value of thickness and mass after elimination of 
the coating was ~67%.
3. Properties of the ?arn and Filaments
The yarns in the warp direction consisted of 54 
individual filaments, whereas the weft consisted 
of two-fold yarns holding 27 filaments each. The 
diameter of each individual filament was approx-
imately 14 μm. Both the yarn linear density and 
FIG. 14: Light microscopy photomicrographs of the 
non-coronary leaflet of the unstented BioValsalva device 
at its cooptation area. The spongiosa is thinner than in 
Figure 13. The outflow surface, i.e., the fibrosa, is highly 
corrugated; this is an abundant amount of underneath col-
lagen fibers. The outflow surface, i.e., the ventricularis, is 
thinner than the fibrosa and holds a large amount of colla-
gen fibers. In both sites, the collagen bundles are parallel 
to the flow surface. The endothelium of both inflow and 
outflow holds only some ghosts of endothelial cells. The 
subendotheliums are intact whereas the valvular intersti-
tial cells are dispersed in the 3 layers of the structures.
the face weave, which had three warps: 10-weft/1-
warp/1-weft twill. The special warp-backed weave 
provided different surface aspects to the inside and 
outside of the fabric tube. The back weave was tak-
en as outflow side of the tube. This structure was de-
signed to guarantee a better support the blood pulse 
pressure in the human body (Figures 26–30).
2. Features of the??abric
The thickness, mass, and porosity of the fabrics were 
obtained after digestion of the Triplex, i.e., specimen 
FIG. 15: Light microscopy photomicrographs of the 
right coronary leaflet of the unstented BioValsalva device 
at its cooptation area. The profile of the fibrosa, which is 
thinner than the ventricularis, is highly corrugated, and 
the collagen bundles are oriented in various directions. 
The spongiosa is well identified. The valvular interstitial 
cells are dispersed in the ventricularis and the fibrosa, but 
scarce in the fibrosa.
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D. Chemical Analysis
1. X-Ray Photoelectron Spectroscopy 
(XPS)
Table 3 lists the surface elemental composition on 
both sides of the stented fabrics before and after clean-
ing with the high-resolution C1s spectra (Figure 32). 
Before cleaning, the inside clearly differs from out-
side in carbon, oxygen, and silicon contents, showing 
much higher oxygen and silicon contents but lower 
carbon content. The difference disappeared after 
cleaning because of the reduced oxygen and silicon 
on the inside. Such changes before and after cleaning 
were also found on the unstented fabrics (data now 
FIG. 16: Light microscopy of the left coronary leaflet 
of the stented BioValsalva device in the cooptation area. 
The spongiosa is almost absent, and the flow surface of 
the fibrosa is highly corrugated. The collagen bundles 
are oriented circumferentially. No endothelium is left, 
but the subendothelium layer is intact. The valvular in-
terstitial cells are abundant throughout the cross-section.
the filament linear density were calculated values 
according to the measuring diameter of filament 
(Table 2). The stretch–strain behaviors of the fila-
ments at both warp and weft directions of the stent-
ed and unstented fabrics are presented in Figure 31. 
The filaments typically exhibited a linear behavior 
below 3% of elongation, which likely represents 
the elastic deformation. Creep occurred at ~5% of 
elongation, followed by a long and almost linear 
increase of stress with strain before reaching ul-
timate failure between 30 and 35% of elongation. 
This final segment of plastic deformation is likely 
associated with sliding among the oriented mac-
romolecules and stress-induced crystallization as 
well. All tested filaments recorded similar stress-
strain behaviors except differences in the ultimate 
elongation.
FIG. 17: Light microscopy of the non-coronary leaflet 
of the stented BioValsalva device in the cooptation area. 
The fibrosa is highly corrugated and shows various thick-
nesses. The spongiosa is almost absent. The ventricular-
is is made of stretched collagen and elastin fibers. The 
interstitial cells are particularly abundant in the fibrosa. 
There is no endothelium left, but the subendothelia are 
well preserved.
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FIG. 18: Light microscopy of the right coronary leaflet 
of the stented BioValsalva device. The flow surface of 
the fibrosa is highly corrugated because of the underneath 
collagen bundles. The spongiosa is ill defined, whereas 
the collagen fibers of the ventricularis are circumferen-
tially oriented. Abundant colonies of valvular interstitial 
cells are dispersed throughout the different layers of the 
leaflet. No endothelium is left on both the inflow and the 
outflow. The subendothelial layers are intact.
FIG. 19: Transmission electron microscopy of the left 
coronary leaflet of the unstented BioValsalva device. 
On the left is an area of scarce collagen content in the 
spongiosa. The cells are well preserved; no halo is vis-
ible either inside on in the vicinity. Some elastin fibers 
are noticeable. The collagen bundles are very loosely 
dispersed. Each filament is well individualized and a 
regular banding is suspected. Meanwhile, the collagen 
bundles of the ventricularis and the fibrosa lie as paral-
lel assemblages of individual fibers. Each fiber shows 
a regular bonding characteristic.
shown). The C1s spectra inside of the fabrics before 
cleaning revealed distinct peaks for C-O and OC=O 
moieties, which almost completely disappeared after 
cleaning. In fact, all cleaned fabrics demonstrated 
similar C1s spectra following cleaning, which resem-
bled hydrocarbons with little oxygen moiety.
2. Fourier Transform Infrared (FTIR)
The FTIR results of the outside and the inside of the 
blood conduit of the BioValsalva prosthesis as re-
ceived and after digestion of the coating are shown 
in Figures 33–34. The characteristic absorption 
spectrum of the outside of the devices as received 
(Figure 33a) indicated that the coating on the out-
side surface is SEPS (styrene ethylene propylene 
styrene block copolymer). Compared with the spec-
trum of the outside of the devices after elimination 
of the coating (Figure 34a), the conclusion that the 
coating has been completely removed can be drawn.
The stretching vibration of C=O group at the 
wave number 1,716 cm-1 and the stretching vibra-
tions of C-O group at 1,247 cm-1 and 1,101 cm-1 
indicated that the material of the fabric for both 
unstented and stented devices is polyester (Figure 
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FIG. 20: Transmission electron microscopy of the non-
coronary leaflet of the unstented BioValsalva device. The 
collagen content of the microphotographs of the left is 
highly dispersed in the spongiosa. The fibrils hold the 
regular banding characteristic of collagen. The elastin 
filaments are very scarce. The collagen bundles are abun-
dant in the ventricularis and the fibrosa. The fibers are, 
individually and in parallel, assembled in bundles sur-
rounding interstitial cells. The banding of the collagen 
filaments is perfectly regular and characteristic.
FIG. 21: Transmission of the right coronary leaflet of 
the unstented BioValsalva device. The collagen content 
of the microphotographs of the left is poorly organized 
and highly dispersed. The ventricular interstitial cells 
are well preserved and the filaments of collagen hold the 
characteristic banding. The collagen content in the other 
layers, i.e., ventricularis and fibrosa, is more abundant, 
but the content of the collagen bundles was limited. The 
filaments are perfectly individualized, showing character-
istic banding.
33b). The spectrum after cleaning was almost the 
same as those prior to cleaning, suggesting that no 
major surface chemical change occurred following 
cleaning (Figure 34b).
The surface chemistry measured with XPS dif-
fered from that measured with FTIR. While FRIP 
data support the PET fabric and SEPS sealing, XPS 
indicated oxygen (likely carbonyl groups)-rich seal-
ing material and oxygen-poor fabric material. The 
known carbon-to-oxygen ratio in PET is 5:2, and 
SEPS does not contain any oxygen. Considering the 
significant difference in sampling depth between 
XPS and FTIR (10 nm vs. higher than 10 microM), 
this discrepancy between XPS and FTIR may well 
reflect the fact that the surface of the sealed pros-
theses contains materials other than SEPS, and the 
“cleaned” surface was actually SEPS rather than 
PET. Therefore, after the cleaning procedure, the 
prosthesis was still covered by SEPS.
3. Differential Scanning Calorimetry (DSC)
Both unstented and stented devices displayed char-
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FIG. 22: Transmission electron microcopy of the left 
coronary leaflet of the stented BioValsalva. The micro-
photographs of the left show a highly cellularized area in 
the spongiosa with dispersed filaments of collagen and 
rare elastin filaments. The cross-section of the poorly as-
sembled bundles of collagen confirms that the individual 
filaments are perfectly individualized. In the areas of 
denser collagen of the ventricularis and the fibrosa, the 
cellularity is well preserved. The bundles of collagen that 
surround the interstitial cells show alternate longitudinal 
views and cross-sections, i.e., waviness. The filaments 
are perfectly individualized and show the regular pattern 
typical of collagen.
acteristics of polyester fiber (Table 4). The premelt 
onset temperature (~248°C), peak melting tempera-
ture (>250°C), premelt end temperature (~254°C), 
melt enthalpy (~50 J/g), and glass transition temper-
ature Tg (~68°C) of unstented and stented devices 
were similar.
IV. DISCUSSION
The well-known Bentall operation has been accept-
ed for several decades.2,4,45 However, there is no real 
consensus regarding the technique that maximizes 
the long-term durability of this procedure.46–48 In a 
nutshell, the technique can be valve sparing or can 
incorporate a valved conduit should the aortic valve 
need to be replaced.49–52
The BioValsalva prosthesis was designed to 
offer a valid option for elderly patients undergoing 
composite aortic root replacement incorporating 
the aortic valve and the aortic root itself; it closely 
matches the aortic root anatomy. This device has the 
capacity to reduce tension on the coronary arteries.53 
FIG. 23: Transmission electron microscopy of the non-
coronary leaflet of the stented BioValsalva. The micro-
graphs of the left show a highly cellularized content dis-
persed in the glucosaminoglycans in the spongiosa. The 
filaments of collagen are loosely assembled in bundles. 
Some scarce elastin filaments can be seen as well. The 
microphotographs of the right show a section with some 
interstitial cells surrounded by bundles of collagen fila-
ments well individualized. Some scarce filaments of elas-
tin are visible as well.
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FIG. 24: Transmission electron microscopy of the right 
coronary leaflet of the stented BioValsalva. The micro-
graphs of the left show a very limited collagen content in 
the spongiosa. There are numerous ventricular interstitial 
cells and dispersed filaments of elastin and collagen. The 
banding of the collagen filaments is perfectly regular. The 
microphotographs of the right show a dense assemblage 
of collagen bundles incorporating scarce elastin fila-
ments and surrounding ventricular interstitial cells. The 
filaments of collagen were well individualized as seen in 
cross-section.
FIG. 25: SEM microphotographs of the cross-section 
of the BioValsalva devices. Both the unstented and the 
stented prostheses show a thin woven fabric (inside) to 
be exposed to the blood flow externally impregnated with 
a thermoplastic polymer, coated with a Teflon film (out-
side). The thermoplastic polymer is strongly anchored to 
the fabric and penetrates deeply in the wall of the polyes-
ter structure filling and the void spaces between the yarns.
The concept of de Paulis is now widely accepted 
because it proved to be flexible. The pseudosinuses 
created by the skirt and the well-defined sinotubular 
junction facilitate near-normal valve function. The 
results achieved by De Paulis et al. have opened new 
avenues of treatment.54–56
This BioValsalva graft provides a more con-
sistent and standardized approach to the Bentall 
procedure involving valve replacement. Surgeons 
now have a device that is directly available in the 
marketplace. It can be trimmed or amended by the 
surgeon according to the patient’s anatomy. The 
need to undertake the sewing of various polyester 
tubes and/or fabric together with an aortic prosthetic 
valve has been eliminated. In other words, the po-
tential shortcomings associated with the intraopera-
tive construction of prosthesis have been consider-
ably reduced.57,58 The quality of the bench testings, 
the controls together with the requirements of the 
regulatory agencies (e.g., the FDA or the CFDA), 
offer additional guarantees.59,60 Such a concept has 
been well accepted with bioprostheses. In addi-
tion, major manufacturers, such as St Jude Medical, 
OnX, and Sorin, manufacture valved conduits of the 
Gelweave Valslava graft fitted with their own me-
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FIG. 26: The structure of the fabric is a ribbed-weave structure. It is a specially wave-backed weave consisting of 
two series of warp threads, face warp (green) and back warp (black), and one series of weft threads (white). The back 
warp interweaves with the wefts to form the back weave, which is 1-warp/1-weft, namely plain weave, while the face 
warps are over the plain weave, where every other two warps orm the face weave, which is 3-warp/1-weft, 1-warp/1-
weft twill. The special warp-backed weave gives different surface aspects to the inside and outside of the fabric tube.
FIG. 27: Scanning electron microscopy of the inside and the outside of the unstented Biovalsalva prosthesis. The 
external surface is smooth and glistening (A1:×100; A2:×2000). The structure of the polyester wave is clearly visible. 
This weave consists of two systems of warps (face wrap and back warp). In this face weave, the face warp is interlaced 
with the left in the ruler of 3/3 twill with an interval of two warps (B1: ×100; B2:×2000).
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chanical valves that are commercially available.61,62 
The concept of valved Valsalva conduit has been 
well accepted after in-depth investigation63–65:
1. The surgical technique has been made 
easier and less time-consuming. The 
resulting blood conduits called Tri-
plex maintain specific characteristics 
that are consistent between grafts. 
The addition of outer elastomeric lay-
ers makes the polyester impervious 
at implantation; thus, any bleeding 
is prevented.66 The Triplex consist of 
three layers (inner polyester, central 
elastomer SEPS, and outer ePTFE 
wrap/film) and has been employed in 
thoracic surgeries, including the aortic 
arch.67
2. The construction of the polyester 
conduit is well designed for surgery. 
The prosthetic valve (stented or not) 
is ready for implantation. The skirt 
has a very attractive construction that 
mimics the Valsalva and allows the 
suturing of the coronary arteries with 
FIG. 28: Scanning electron microscopy of the inside and the outside of the unstented Biovalsalva prosthesis after 
cleaning. The side-by-side photos of the outside and the inside confirm that the weave of the polyester fabric (face 
warp and back warp) and one system of weft. The face weave is formed by interlacing face warp and weft. The back 
weave is formed by interlacing back warp and weft. The back weave is a traditional plain weave; in the face weave, 
the warp is interlaced with the weft in 3/3 twill with an interval of two warps.
Fu et al.
Journal of Long-Term Effects of Medical Implants
68
FIG. 29: Scanning electron microscopy of the outside and inside the of the stented Biovalsalva prosthesis as received 
from the manufacture. Both the outside and the inside observation are similar to those of the unstented device.
FIG. 30: Scanning electron microscopy of the outside and inside of the stented Biovalsalva prosthesis after cleaning 
and eliminating the external coating. The structure of the polyester fabric was identical to the one observed in the 
unstented device.
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5.44±0.10 Warp rib weave* 0.272±0.004 0.0124±0.0003 66.9638.18
 Stented
4.20±0.06 3.85±0.09
5.48±0.04 Warp rib weave* 0.271±0.003 0.0123±0.0002 67.1668.05
*Note: All the data come from the fabric of the body after cleaning.
TABLE 2: Yarn and Filament Features of Fabric
Unstented Stented
Upper Warp Inner Warp Weft Upper Warp Inner Warp Weft
No. of filaments in 
each yarn 54 54 27×2 54 54 27×2
Yarn linear density* 
(dtex) 110.44 109.00 106.46 108.68 111.73 108.04
Filament diameter 
(um) 13.74±0.60 13.65±0.55 13.49±0.45 13.63±0.55 13.82±0.55 13.59±0.64
Filament linear den-
sity* (dtex) 2.05 2.02 1.97 2.01 2.07 2.00
Filament tensile 
elongation(%)
32.56±2.30 30.49±2.75 31.72±2.11 33.10±2.99 31.23±2.71 35.23±2.16
Filament tensile 






dtex) 3.60±0.18 3.58±0.17 3.74±0.18 3.65±0.20 3.59±0.16 3.73±0.19






dtex) 13.55±0.55 14.22±1.10 14.81±1.56 13.51±0.96 13.47±1.24 13.54±0.84
(Mpa)* 1870.52 1961.88 2043.71 1863.90 1859.07 1867.83
*Note: All the data were obtained from the fabric of the body after cleaning. The yarn linear density and the fila-
ment linear density were both calculated according to the measured diameter of the filament. The values of filament 
tensile breakage strength and filament modulus of elasticity in Mpa were both converted from the unit in cN/dtex.
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considerably reduced tensions. The 
body, with its crimps perpendicular to 
the blood flow, can be tailored accord-
ing to the requirements of the anatomy 
of the patients.68–70
3. The polyester fabrics selected to man-
ufacture the BioValsalva appear to be 
well adapted for this procedure. They 
are made totally impervious by the ap-
plication of a thermoplastic elastomer 
and an outer PTFE wrap/film that is 
thermally bonded. This kind of fabric 
is strong enough to resist long-term 
dilatation and/or degradation. Its use 
in open vascular surgery has not been 
associated with device-related adverse 
events.37,71
4. Chemically processed porcine valves 
have been implanted for 50 years and 
are acknowledged as a satisfactory de-
vice. The selection of a porcine valve 
to manufacture the Triplex Biovalsalva 
prosthesis makes sense. Porcine tissue 
is less structurally homogeneous than 
bovine tissue with respect to collagen 
and fiber tissue orientation.72,73 The 
porcine valve leaflet does contain a 
spongiosa layer. This spongiosa ac-
cumulates large amounts of hydrated 
proteoglycans and/or polysaccharides 
that reduce friction between the ven-
tricularis and the fibrosa. The spongio-
sa is loose and watery and is of varying 
thickness; it forms the core of the cusp 
near the base, proximal to the aortic 
wall. The spongiosa consists of radi-
ally oriented collagen fibers and cells 
scarcely disperse. It is proximately ab-
sent near the free edge. The spongiosa 
FIG. 31: Load elongation curve of the filaments. For each kind of yarn (upper warp, inner warp and weft, both on 
unstented and stented devices), 20 filaments were chosen randomly from 10 different yarns for the filament tensile 
test. The data presented in the table are the mean value of the 20 times tests.
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TABLE 3: Surface Elemental Composition Measured with XPS
BioValslava
Elemental Composition (%)
C O N Ca Na Zn Si
Side A
Before cleaning 67.5 25.3 0.5 0.2 0.1 0.4 6.0
After cleaning 87.2 9.3 0.3 0.2 0.2 1.1 1.7
Side B
Before cleaning 88.6 8.3 0.3 0.2 0.1 0.3 2.1
After cleaning 88.7 8.1 0.4 0.2 0.2 0.4 2.0
FIG. 32: High-resolution C1s spectra of the BioValsava prostheses measured with XPS, showing the distinct presence 
of oxygen moieties inside the non-cleaned fabrics, and the similar spectra after cleaning.
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gives the cusp of the leaflet its deform-
ability and allows the collagen and the 
elastin fibers to easily slide over each 
other during the cardiac cycle. The 
fibrosa also dampen the vibrations 
in the fibrosa associated with leaflet 
deformation during diastole. The val-
vular interstitial cells are dispersed in 
the three layers of the leaflets. They 
primarily contribute to maintain the 
structural integrity of the leaflet tissue. 
These valvular interstitial cells have 
the characteristics of both fibroblasts 
and smooth muscle cells. However, 
they do not survive to the chemical 
processing of the tissues.74
The chemical processing of the porcine aortic 
valve results in the cross linking of proteins, espe-
cially collagen. The glutaraldehyde proved to be the 
most efficient; it inhibits autolysis, enhances the me-
chanical stability, and creates the possibility of hav-
ing valves available from the shelf. Other chemicals, 
such as formalin, epoxy, and carbodiimide, are now 
history. The fixation locks the structure at one phase 
of the cardiac cycle.75 It is accompanied by the loss 
of endothelium, interstitial cell viability, and colla-
gen bundles. Therefore, as a result of the chemical 
processing of the tissues, the porcine aortic valve 
totally loses its viability. It is misappropriately iden-
tified as a bioprosthesis. Based upon the practice of 
the last several decades, this product cannot be chal-
lenged. However, it is a singular material, and the 
quality of this material depends upon the conditions 
of processing. These valves differ in many respects 
from native valves, for example, in their opening 
and closing.
Stented porcine valves are made from a single 
pig valve sewn onto a plastic stent whose bone is re-
inforced with a metal ring. The stent and the ring are 
covered with a polyester cloth. Unstented porcine 
FIG. 33: FTIR of the outside and the inside of the blood conduit of the BioValsalva prosthesis as received.
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Unstented 248.2 251.4 254.1 50.9 73.0
Stented 247.4 250.4 249.1 49.8 68.0
*Note: All the data come from the fabric of the body after cleaning.
FIG. 34: FTIR of the outside and the inside of the blood conduit of the BioValsalva prosthesis after digestion of the 
coating.
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valves are also made from a single pig valve by re-
moving the entire aortic root and adjacent aorta.32–37 
They are scalloped before they are sutured to the 
Triplex tube.39,40 There is no real benefit to use the 
leaflet of different aortic valves as in the Hancock 
MO bioprosthesis.76 This concept was based on the 
stiffness of the septal leaflet. Despite differences in 
the size and morphology of the leaflets, selecting 
valves from a single pig appears to be the most ap-
propriate approach.
The right coronary leaflet is the longest and the 
non-coronary the smallest. The manufacture of the 
bioprosthesis follows a very careful examination of 
the aortic valve with naked eye. Practically every 
leaflet can be divided into several areas. The ap-
positional area is the strip where the leaflets touch 
one another. The non-appositional area is the strip 
where the leaflet is anchored to the aortic wall. This 
non-commissural area does not touch the other two 
leaflets; it is the pressure bearing surface. The leaflet 
flexion area is the curvature of the leaflet observed 
in the region of transition between the appositional 
and non-appositional parts.77
The inflow surface is always rougher, with a 
complete loss of endothelial cells. The outflow sur-
face made of the subendothelial layer is smoother 
but is devoid of endothelial cells that are destroyed 
during the tissue processing. Every valve consists 
of three main sections that can be considered in 
parallel: ventricularis, spongiosa, and fibrosa from 
the inflow to the outflow. The interstitial cells do not 
retain their viability during chemical processing.
Some authors recommend the decellularization 
of the leaflet to remove the major cellular immu-
nological components.78 However, in vivo, such a 
treatment does not present any evident advantage.79 
In the valves hereby selected, high celluarity was 
well evidenced, scarce elastic fibers were visible, 
and collagen was always present with various ori-
entations. Inflammatory cells were present as well. 
The strict rules of the fixation procedure guarantee 
the durability of the valve, whereas decellulariza-
tion treatment causes major alterations to the bio-
logical structures.81–84
Thus, the BioValsalva conduit fulfills the 3Bs: 
biocompatibility, biofunctionality, and biodurability. It 
provides important benefits for the Bentall procedure.42
The additional anticipated benefits of the 
BioValsalva devices compared to the Valsalva fit-
ted with a mechanical valve consist in the absence 
of mandatory administration of long-term blood 
thinners to the patients. This is particularly impor-
tant in elderly patients or in countries where antico-
agulants are very expensive. However, the valved 
conduits hosting a mechanical valve offer the ad-
vantage of durability. Whereas the Gelweave Val-
salva is stored dry and might theoretically become 
a biosynthetic conduit after the gelatin is digested, 
the Triplex BioValsalva prosthesis is preserved 
in a solution of low-concentration glutaraldehyde 
because of the porcine bioprosthesis. This concept 
makes the wall of the blood conduit stiffer, and the 
in vivo degradability of the seal has not yet been 
documented. Harvesting devices at autopsy and/
or reoperation will allow us to investigate the fate 
of this polymer coating. The Triplex BioValsalva 
prosthesis, because of the storage in a solution of 
glutaraldehyde, must be abundantly rinsed prior to 
implantation.
V. CONCLUSION
Triplex BioValsalva grafts offer an avenue to bet-
ter reconstruct the anatomy of the aortic root with 
respect to the 3Bs: biofunctionality, biodurability, 
and biocompatibility. The unique features of these 
prostheses are (1) a short section of polyester wo-
ven with a belly shape parallel to the blood flow, 
(2) the shape of the skirt in which length is equal 
to the aorta diameter with some capacity to expand 
its diameter after pressurization, and (3) the gen-
eration of pseudo-sinuses of Valsalva. It is sutured 
to the body a polyester tube whose crimps are per-
pendicular to the blood flow that can be tailored by 
the surgeon at implantation. However, the Bentall 
procedure remains a challenge, and adverse events 
cannot be fully eliminated. Overall, this device can 
contribute to the prevention of device-related ad-
verse events.
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